Literature DB >> 9199629

Rapid brain autopsy. The Joseph and Kathleen Bryan Alzheimer's Disease Research Center experience.

C M Hulette1, K A Welsh-Bohmer, B Crain, M H Szymanski, N O Sinclaire, A D Roses.   

Abstract

OBJECTIVE: To develop a system for retrieving brain tissue within 1 hour after death in an effective and useful manner.
DESIGN: Nurse clinicians were employed as study co-ordinators and were available to families 24 hours each day.
SETTING: Autopsies were performed at Duke University Medical Center, Durham, NC, from 1985 through 1995. PARTICIPANTS: Neuropathology faculty, fellows, and residents, autopsy technicians; and brain bank staff.
RESULTS: Fifty-one rapid autopsies with a postmortem interval of less than 1 hour have been performed. Four of these were normal controls, three were disease controls, and 44 represented Alzheimer's disease patients. Tissue retrieved at rapid autopsy has been distributed to 93 research teams, 30 of these located at Duke University Medical Center. Many researchers have received multiple shipments of tissue.
CONCLUSIONS: The Bryan Alzheimer's Disease Research Center Rapid Autopsy Program at Duke University Medical Center has been successful in retrieving tissue from individuals with dementia and also from controls within 1 hour of death. The critical features of the success of this program have been the use of nurse clinicians who work closely with patients and their families to ensure a successful autopsy at the time of death and the maintenance of a 24-hour call schedule for nurses and neuropathology staff. Similar programs can be implemented for experimental work into the pathogenesis of a wide variety of human diseases in which the examination of human tissue is required.

Entities:  

Mesh:

Year:  1997        PMID: 9199629

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  32 in total

1.  Cytoplasmic aggregates of phosphorylated extracellular signal-regulated protein kinases in Lewy body diseases.

Authors:  Jian-Hui Zhu; Scott M Kulich; Tim D Oury; Charleen T Chu
Journal:  Am J Pathol       Date:  2002-12       Impact factor: 4.307

2.  Metabolomic changes in autopsy-confirmed Alzheimer's disease.

Authors:  Rima Kaddurah-Daouk; Steve Rozen; Wayne Matson; Xianlin Han; Christine M Hulette; James R Burke; P Murali Doraiswamy; Kathleen A Welsh-Bohmer
Journal:  Alzheimers Dement       Date:  2010-11-13       Impact factor: 21.566

3.  Comparison of Metal Levels between Postmortem Brain and Ventricular Fluid in Alzheimer's Disease and Nondemented Elderly Controls.

Authors:  Steven T Szabo; G Jean Harry; Kathleen M Hayden; David T Szabo; Linda Birnbaum
Journal:  Toxicol Sci       Date:  2015-12-31       Impact factor: 4.849

4.  Gene expression correlates of neurofibrillary tangles in Alzheimer's disease.

Authors:  Travis Dunckley; Thomas G Beach; Keri E Ramsey; Andrew Grover; Diego Mastroeni; Douglas G Walker; Bonnie J LaFleur; Keith D Coon; Kevin M Brown; Richard Caselli; Walter Kukull; Roger Higdon; Daniel McKeel; John C Morris; Christine Hulette; Donald Schmechel; Eric M Reiman; Joseph Rogers; Dietrich A Stephan
Journal:  Neurobiol Aging       Date:  2005-10-19       Impact factor: 4.673

5.  Twenty-first century brain banking. Processing brains for research: the Columbia University methods.

Authors:  Jean Paul G Vonsattel; Maria Pilar Del Amaya; Christian E Keller
Journal:  Acta Neuropathol       Date:  2007-11-06       Impact factor: 17.088

6.  Twenty-first century brain banking: practical prerequisites and lessons from the past: the experience of New York Brain Bank, Taub Institute, Columbia University.

Authors:  Jean Paul G Vonsattel; Maria del Pilar Amaya; Etty Paola Cortes; Katerina Mancevska; Christian E Keller
Journal:  Cell Tissue Bank       Date:  2008-06-26       Impact factor: 1.522

7.  Cerebrospinal fluid dehydroepiandrosterone levels are correlated with brain dehydroepiandrosterone levels, elevated in Alzheimer's disease, and related to neuropathological disease stage.

Authors:  Jennifer C Naylor; Christine M Hulette; David C Steffens; Lawrence J Shampine; John F Ervin; Victoria M Payne; Mark W Massing; Jason D Kilts; Jennifer L Strauss; Patrick S Calhoun; Rohana P Calnaido; Daniel G Blazer; Jeffrey A Lieberman; Roger D Madison; Christine E Marx
Journal:  J Clin Endocrinol Metab       Date:  2008-05-13       Impact factor: 5.958

8.  Stakeholders' Perceptions and Information Needs Regarding Research Medical Donation.

Authors:  Andrew S Epstein; Jada G Hamilton; Elyse Shuk; Danielle R Romano; Kathleen Lynch; Erva Khan; Margaux Genoff; Chelsea Michael; Christine Iacobuzio-Donahue
Journal:  J Pain Symptom Manage       Date:  2019-07-11       Impact factor: 3.612

9.  A SAGE study of apolipoprotein E3/3, E3/4 and E4/4 allele-specific gene expression in hippocampus in Alzheimer disease.

Authors:  Pu-Ting Xu; Yi-Ju Li; Xue-Jun Qin; Charles Kroner; Anya Green-Odlum; Hong Xu; Tian-Yuan Wang; Donald E Schmechel; Christine M Hulette; John Ervin; Mike Hauser; Jonathan Haines; Margaret A Pericak-Vance; John R Gilbert
Journal:  Mol Cell Neurosci       Date:  2007-07-24       Impact factor: 4.314

10.  Cerebrovascular smooth muscle actin is increased in nondemented subjects with frequent senile plaques at autopsy: implications for the pathogenesis of Alzheimer disease.

Authors:  Christine M Hulette; John F Ervin; Yvette Edmonds; Samantha Antoine; Nicolas Stewart; Mari H Szymanski; Kathleen M Hayden; Carl F Pieper; James R Burke; Kathleen A Welsh-Bohmer
Journal:  J Neuropathol Exp Neurol       Date:  2009-04       Impact factor: 3.685

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.